We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.AuthorsHyams, David; Chan, Arlene; Oliveira, Celia; Snyder, Raymond; Vinholes, Jeferson; Audeh, M.; Alencar, Victor; Lombard, Janine; Mookerjee, Bijoyesh; Xu, John; Brown, Kathryn; Klein, PaulaPublicationInvestigational New Drugs, 2013, Vol 31, Issue 5, p1345ISSN0167-6997Publication typearticleDOI10.1007/s10637-013-9991-2